Puravankara Ltd
NSE:PURVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Puravankara Ltd
NSE:PURVA
|
IN |
|
C
|
CNB Corp
OTC:CNBW
|
US |
|
K
|
Kub Malaysia Bhd
KLSE:KUB
|
MY |
|
M
|
Mercator Medical SA
WSE:MRC
|
PL |
|
Y
|
YB Ventures Bhd
KLSE:YB
|
MY |
Wall Street
Price Targets
PURVA Price Targets Summary
Puravankara Ltd
According to Wall Street analysts, the average 1-year price target for
PURVA
is 408 INR
with a low forecast of 404 INR and a high forecast of 420 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PURVA's stock price target?
Price Target
408
INR
According to Wall Street analysts, the average 1-year price target for
PURVA
is 408 INR
with a low forecast of 404 INR and a high forecast of 420 INR.
What is Puravankara Ltd's Revenue forecast?
Projected CAGR
27%
For the last 13 years the
compound annual growth rate for
Puravankara Ltd's revenue is
7%.
The projected
CAGR
for the next 3 years is
27%.
What is Puravankara Ltd's Operating Income forecast?
Projected CAGR
50%
For the last 13 years the
compound annual growth rate for
Puravankara Ltd's operating income is
-2%.
The projected
CAGR
for the next 3 years is
50%.
